Previous research has shown that cytotoxic CD8 T cells [12,13], T helper type 1 (Th1) cells [14]), follicular helper T (Tfh) cells [15] and natural killer (NK) cells [16] were strongly associated with patient survival or response to therapy in BC. This evidence concerns the gene CD8A and breast cancer.